161 related articles for article (PubMed ID: 21969926)
1. A case of adalimumab-induced pneumonitis in a 45-year-old man with Crohn's disease.
Reid JD; Bressler B; English J
Can Respir J; 2011; 18(5):262-4. PubMed ID: 21969926
[TBL] [Abstract][Full Text] [Related]
2. Listeria monocytogenes infection in Crohn's disease treated with adalimumab.
Willson KJ; Jacob A; Shetti MP; Bhatia R; Yee K; Osler W
Med J Aust; 2012 Oct; 197(8):466-7. PubMed ID: 23072245
[No Abstract] [Full Text] [Related]
3. Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.
Petitpain N; Bornert-Keller N; Peyrin-Biroulet L
J Crohns Colitis; 2013 Oct; 7(9):e396. PubMed ID: 23523265
[No Abstract] [Full Text] [Related]
4. Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review.
Cesarini M; Angelucci E; Foglietta T; Vernia P
J Crohns Colitis; 2011 Dec; 5(6):619-22. PubMed ID: 22115384
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease.
Casanova MJ; Chaparro M; Valenzuela C; Cisneros C; Gisbert JP
World J Gastroenterol; 2015 Feb; 21(7):2260-2. PubMed ID: 25717268
[TBL] [Abstract][Full Text] [Related]
6. Sarcoidosis complicating treatment with adalimumab for Crohn's disease.
McDonnell MJ; Rutherford RM; O'Regan A
J Crohns Colitis; 2014 Sep; 8(9):1140-1. PubMed ID: 24631310
[No Abstract] [Full Text] [Related]
7. Adalimumab-induced psoriasis in a patient with Crohn's disease.
Korkmaz U; Duman AE; Dindar G; Yilmaz H; Dursun IH; Celebi A; Senturk O; Hulagu S
Indian J Gastroenterol; 2013 Mar; 32(2):135-6. PubMed ID: 23151897
[No Abstract] [Full Text] [Related]
8. [Level of adalimumab and its antibody titers define the effectiveness of the biological (anticytokine) therapy in Crohn's disease].
Lazebnik LB; Sagynbaeva VÉ
Eksp Klin Gastroenterol; 2013; (7):18-22. PubMed ID: 24772870
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis and pneumonitis during adalimumab therapy in Crohn disease: mind the histoplasmosis!
Pinheiro Bdo V; Delgado Ade A; Chebli JM
Arq Gastroenterol; 2014; 51(1):73-6. PubMed ID: 24760069
[TBL] [Abstract][Full Text] [Related]
10. Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease.
Casanova MJ; Chaparro M; Martínez S; Vicuña I; Gisbert JP
J Crohns Colitis; 2012 Dec; 6(10):1034-7. PubMed ID: 22534313
[TBL] [Abstract][Full Text] [Related]
11. Treating Crohn's disease: at "deep" remission and exploring beyond.
Corte C; Selby WS
Med J Aust; 2012 Oct; 197(8):430-1. PubMed ID: 23072227
[No Abstract] [Full Text] [Related]
12. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
Haennig A; Bonnet D; Thebault S; Alric L
Gastroenterol Clin Biol; 2010 Sep; 34(8-9):e7-8. PubMed ID: 20189334
[No Abstract] [Full Text] [Related]
13. Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease.
Emmert MY; Salzberg SP; Emmert LS; Behjati S; Plass A; Felix C; Falk V; Gruenenfelder J
Eur J Heart Fail; 2009 Nov; 11(11):1106-9. PubMed ID: 19875411
[TBL] [Abstract][Full Text] [Related]
14. [Adalimumab for the treatment of adult Crohn's disease--update of a consensus report by the Working Group Inflammatory Bowel Disease of the Austrian Society of Gastroenterology and Hepatology].
Novacek G; Haas T; Knoflach P; Petritsch W; Tilg H; Vogelsang H; Reinisch W
Z Gastroenterol; 2013 Sep; 51(9):1101-9. PubMed ID: 23996653
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
Behm BW; Bickston SJ
Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of Adalimumab in Crohn's disease].
Serghini M; Haddad W; Jeddi H; Karoui S; Ben Mustapha N; Kallel L; Fekih M; Matri S; Boubaker J; Filali A
Tunis Med; 2012 Feb; 90(2):101-7. PubMed ID: 22407620
[TBL] [Abstract][Full Text] [Related]
17. Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study.
Condino G; Calabrese E; Zorzi F; Onali S; Lolli E; De Biasio F; Ascolani M; Pallone F; Biancone L
Dig Liver Dis; 2013 Mar; 45(3):258-62. PubMed ID: 23195667
[TBL] [Abstract][Full Text] [Related]
18. Stevens-Johnson syndrome complicating adalimumab therapy in Crohn's disease.
Salama M; Lawrance IC
World J Gastroenterol; 2009 Sep; 15(35):4449-52. PubMed ID: 19764100
[TBL] [Abstract][Full Text] [Related]
19. Hemidiaphragm paresis and granulomatous pneumonitis associated with adalimumab: a case report.
Abdallah T; Abdallah M; Saifan C; El Sayegh D; Chalhoub M; Sasso L
Heart Lung; 2014; 43(1):84-6. PubMed ID: 24246727
[TBL] [Abstract][Full Text] [Related]
20. Adalimumab for Crohn's disease after infliximab treatment failure: a systematic review.
Da W; Zhu J; Wang L; Lu Y
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):885-91. PubMed ID: 23817447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]